Crescent Capital Partners

Investor type

PE

Founded

2000

AUM

$4 500 M

Location

Sydney, New South Wales, Australia

$100+ m

Investment Ticket

3-5 years

Investment Horizon

Series B, Late Stage (Series C+)

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

Crescent Capital Partners (Crescent) is one of the oldest and most successful Australian-based private equity and alternative asset firms. Founded in 2000, Crescent began as a private equity firm focused on mid-market ‘growth buy-out’ transactions and is today an alternative asset manager continuing to cover Australian and New Zealand private equity but also offering private credit and active listed equities fund products.
As a private equity manager, Crescent is a top quartile global fund manager (as measured by Cambridge Associates benchmarks) with a strong track record in delivering superior returns to investors that is the hallmark of its success to date. Crescent has closed multiple funds since its inception with total capital raised in excess of A$4.5 billion.
Crescent is well known for its deep experience and skill set in investing into healthcare, industrial, financial and services businesses, and we use this expertise and deep sector knowledge to inform investment decisions. In particular, Crescent has been the most active private equity manager in healthcare transactions in Australia measured by number of investments made over the past 10 years.
Crescent is offering wholesale investors access to its various funds through direct investment and via recognised wealth platforms.

Industry

Consumer Products Education Financial Services Healthcare Services Industrial Other Fintech Food and Beverage Foodtech Energy HealthTech

Region of investment

Australia and others

Crescent Capital Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Crescent Capital Partners Fund VI
Private Equity (PE)
Food and Beverage
Foodtech
Healthcare Services
Energy
HealthTech
Series B
Late Stage (Series C+)
Australia and others
$5-10 m
$529 M
August 2018
Crescent Capital Partners Fund VII
Private Equity (PE)
Healthcare Services
Energy
HealthTech
Series B
Late Stage (Series C+)
Australia and others
$5-10 m
$670 M
April 2023

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
Jey6rnP3FvNoTwU2 Jey6rnP3FvNoTwU2
Jey6rnP3FvNoTwU2
avatar
Jey6rnP3FvNoTwU2 Jey6rnP3FvNoTwU2
Jey6rnP3FvNoTwU2
avatar
Jey6rnP3FvNoTwU2 Jey6rnP3FvNoTwU2
Jey6rnP3FvNoTwU2
avatar
Jey6rnP3FvNoTwU2 Jey6rnP3FvNoTwU2
Jey6rnP3FvNoTwU2
avatar
Jey6rnP3FvNoTwU2 Jey6rnP3FvNoTwU2
Jey6rnP3FvNoTwU2
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Crescent Capital Partners

Crescent Capital Partners is located in Sydney, New South Wales, Australia.
Crescent Capital Partners was founded in 2000.
Crescent Capital Partners invests in companies and startups in Consumer Products, Education, Financial Services, Healthcare Services, Industrial, Other, Fintech, Food and Beverage, Foodtech, Energy, HealthTech.
Crescent Capital Partners invests in companies and startups in Australia and others.
Crescent Capital Partners invests in companies and startups at Series B, Late Stage (Series C+).
Crescent Capital Partners usually invests $100+ m on average.
Crescent Capital Partners has around $4 500m assets under management.
Crescent Capital Partners last fund was created/launched in 2023-04-14